RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)

CUSIP: 75955J402

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock ($.001 par value)
Shares outstanding
74,702,121
Total 13F shares
9,944,006
Share change
+382,542
Total reported value
$318,306,821
Put/Call ratio
43%
Price per share
$32.01
Number of holders
83
Value change
+$11,580,961
Number of buys
38
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q2 2021

As of 30 Jun 2021, RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,944,006 shares. The largest 10 holders included RTW INVESTMENTS, LP, BlackRock Inc., VR Adviser, LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, CITADEL ADVISORS LLC, STATE STREET CORP, Ikarian Capital, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 83 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.